Mutant enzymes
US-2015376580-A1 · Dec 31, 2015 · US
Method for producing myo-inositol and myo-inositol derivative
US9994871B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9994871-B2 |
| Application number | US-201615076830-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 22, 2016 |
| Priority date | Nov 14, 2011 |
| Publication date | Jun 12, 2018 |
| Grant date | Jun 12, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
To impart significantly improved myo-inositol producing capability, suitable for use in recombinant DNA techniques and synthetic biology methods, to a host microorganism that does not possess an endogenous myo-inositol biosynthesis pathway, such as Escherichia coli . Inositol monophosphatase activity is strengthened in a transformant obtained by introducing a myo-inositol biosynthesis pathway into a host microorganism that does not possess an endogenous myo-inositol biosynthesis pathway.
First claim
Opening claim text (preview).
The invention claimed is: 1. A compound of Chemical Formula 2: 2. A composition comprising the compound of claim 1 .
Assignees
Inventors
Classifications
Antihyperlipidemics · CPC title
- C12P7/02Primary
containing a hydroxy group · CPC title
Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins · CPC title
- C12P19/46Primary
having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin · CPC title
acting on ester bonds (3.1) · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9994871B2 cover?
- To impart significantly improved myo-inositol producing capability, suitable for use in recombinant DNA techniques and synthetic biology methods, to a host microorganism that does not possess an endogenous myo-inositol biosynthesis pathway, such as Escherichia coli . Inositol monophosphatase activity is strengthened in a transformant obtained by introducing a myo-inositol biosynthesis pathway …
- Who is the assignee on this patent?
- Asahi Kasei Chemicals Corp
- What technology area does this patent fall under?
- Primary CPC classification C12P7/02. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).